ArticleEClinicalMedicine2024

Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial.

Morten S Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.